Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Asenapine 3x5mg vs 1x15mg in Schizophrenia
NCT01101464Phase 2Completed
- Sponsor
- Organon & Co.
- Start
- Oct 2002
- Primary completion
- Dec 2002
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of asenapine in schizophrenia, schizoaffective disorder, sponsored by Organon & Co.. Started Oct 2002; status: completed.
02
Drugs
asenapine
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT01101464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01101464.